Nishino Takeshi, Yamamoto Yota, Ikeda Mayumi, Morimoto Masami, Furukawa Takako, Goto Masakazu, Furukita Yoshihito, Takechi Hirokazu, Seike Junichi, Tangoku Akira, Fujiwara Haruo
Dept. of Thoracic Endocrine Surgery and Oncology, Tokushima University Hospital, Japan.
Gan To Kagaku Ryoho. 2013 May;40(5):643-6.
The patient was a 64-year-old man, diagnosed as cStage IVa esophageal cancer invading the aorta with lymph node metastasis. He received combination chemotherapy with docetaxel/cisplatin/5-FU(DFP therapy). After one course, CT and endoscopic examination showed remarkable reduction of the primary lesion and lymph node metastasis. We performed subtotal esophagectomy and gastric tube reconstruction by the retroposterior mediastinum route. The pathological specimen evidenced fibrosis and infiltration of inflammatory cells on almost all layers, but showed no viable malignant cells in the middle thoracic esophagus. Therefore, the pathological effect was judged as Grade 3(pCR). This case suggested that DFP combination chemotherapy may prove to be a useful treatment for advanced esophageal cancer with invasion to other organs.
该患者为一名64岁男性,被诊断为IVa期食管癌,侵犯主动脉并伴有淋巴结转移。他接受了多西他赛/顺铂/5-氟尿嘧啶联合化疗(DFP疗法)。一个疗程后,CT和内镜检查显示原发灶和淋巴结转移明显缩小。我们通过后纵隔途径进行了食管次全切除术和胃管重建术。病理标本显示几乎所有层面均有纤维化和炎症细胞浸润,但中胸段食管未见存活的恶性细胞。因此,病理疗效判定为3级(pCR)。该病例表明,DFP联合化疗可能是治疗侵犯其他器官的晚期食管癌的一种有效方法。